00:28:51 Europe / Stockholm

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande



2023-05-30 Ordinarie utdelning LIDDS 0.00 SEK
2023-05-29 Kvartalsrapport 2023-Q1
2023-05-29 Årsstämma 2023
2023-03-13 Bokslutskommuniké 2022
2023-01-09 Extra Bolagsstämma 2022
2022-11-28 Kvartalsrapport 2022-Q3
2022-08-25 Kvartalsrapport 2022-Q2
2022-06-02 Ordinarie utdelning LIDDS 0.00 SEK
2022-06-01 Årsstämma 2022
2022-05-24 Kvartalsrapport 2022-Q1
2022-02-23 Bokslutskommuniké 2021
2021-11-22 Kvartalsrapport 2021-Q3
2021-08-26 Kvartalsrapport 2021-Q2
2021-05-18 Ordinarie utdelning LIDDS 0.00 SEK
2021-05-18 Kvartalsrapport 2021-Q1
2021-05-17 Årsstämma 2021
2021-02-25 Bokslutskommuniké 2020
2020-11-19 Kvartalsrapport 2020-Q3
2020-08-20 Kvartalsrapport 2020-Q2
2020-05-15 Ordinarie utdelning LIDDS 0.00 SEK
2020-05-14 Årsstämma 2020
2020-05-14 Kvartalsrapport 2020-Q1
2020-02-27 Bokslutskommuniké 2019
2019-11-28 Kvartalsrapport 2019-Q3
2019-08-29 Kvartalsrapport 2019-Q2
2019-05-17 Ordinarie utdelning LIDDS 0.00 SEK
2019-05-16 Årsstämma 2019
2019-05-16 Kvartalsrapport 2019-Q1
2019-02-28 Bokslutskommuniké 2018
2018-11-29 Kvartalsrapport 2018-Q3
2018-08-30 Kvartalsrapport 2018-Q2
2018-05-17 Ordinarie utdelning LIDDS 0.00 SEK
2018-05-16 Kvartalsrapport 2018-Q1
2018-05-16 Årsstämma 2018
2018-02-22 Bokslutskommuniké 2017
2017-11-09 Kvartalsrapport 2017-Q3
2017-10-06 Extra Bolagsstämma 2017
2017-08-31 Kvartalsrapport 2017-Q2
2017-05-12 Ordinarie utdelning LIDDS 0.00 SEK
2017-05-11 Årsstämma 2017
2017-05-11 Kvartalsrapport 2017-Q1
2017-02-23 Bokslutskommuniké 2016
2016-10-27 Kvartalsrapport 2016-Q3
2016-08-24 Kvartalsrapport 2016-Q2
2016-06-09 Extra Bolagsstämma 2016
2016-04-22 Årsstämma 2016
2016-04-22 Kvartalsrapport 2016-Q1
2016-04-21 Ordinarie utdelning LIDDS 0.00 SEK
2016-02-10 Bokslutskommuniké 2015
2015-10-29 Kvartalsrapport 2015-Q3
2015-08-13 Kvartalsrapport 2015-Q2
2015-04-22 Ordinarie utdelning LIDDS 0.00 SEK
2015-04-21 Kvartalsrapport 2015-Q1
2015-04-21 Årsstämma 2015
2015-02-20 Bokslutskommuniké 2014
2014-11-11 Kvartalsrapport 2014-Q3
2014-08-21 Kvartalsrapport 2014-Q2


ListaFirst North Stockholm
LIDDS är ett läkemedelsbolag. Bolaget utvecklar läkemedelsprodukter baserade på en patentskyddad och kliniskt testad drug delivery-teknologi. Egenskaperna hos produkterna utgör grunden för LIDDS teknologiplattform för utveckling av injicerbara läkemedelsprodukter. LIDDS är förkortningen för Local Intelligent Drug Delivery System och bolaget har sitt huvudkontor i Uppsala.
2022-07-15 11:00:00

UPPSALA, SWEDEN – LIDDS AB (publ) announces today that Anders Månsson will assume the role of Chief Executive Officer for LIDDS, effective September 1st 2022 succeeding Nina Herne.

Anders Månsson has broad experience from leading roles both in the biotech sector and in larger multinational pharmaceutical companies in an international setting over 25 years. His substantial experience in business development from serving as e.g VP & Head of Global Business Development in LEO Pharma will be important for LIDDS in driving the value of current and future collaborations. Anders also has considerable experience from sales & marketing; he has been the Managing Director of a subsidiary in Ferring Pharmaceuticals, and he has headed a major global business unit in LEO Pharma. His experience also includes board-level and executive appointments in biotech companies, and most recently Anders was the CEO of RhoVac.

“I am convinced Anders will be a great leader taking LIDDS to the next level with his experience from licensing and deal-making”, says Jan Törnell, chairman of LIDDS. “Anders has the right leadership capabilities to drive LIDDS and deliver on our business development activities and internal portfolio”.

“I see in LIDDS a company with a proprietary technology platform, that already has a proof of concept with multiple compounds in clinical trials, and that can be applied and licensed over and over again with different known APIs and in different indications where targeted controlled release brings a significant therapeutic advantage”, says Anders Månsson. “I see these opportunities for licensing as virtually endless and, as such, I am thrilled to join the company at this early stage of its growth journey.”

Anders will join LIDDS September 1st.

“We would like to thank Nina for developing LIDDS in an excellent way”, says Jan Törnell “She has successfully led LIDDS through an important transformation period building the organization, creating a strategic vision, and optimizing its processes and portfolio creating a much stronger and solid LIDDS”.

Nina will remain as CEO until Anders is in place to secure a smooth transition.

Nina is leaving LIDDS due to personal reasons.

For additional information, please contact:
Jan Törnell, Chairman LIDDS
Phone:+46 (0)70 676 0008 
E-mail: jan.tornell@innoext.se

LIDDS’ Certified Adviser is Redeye AB
Tel: +46 (0)8 121 576 90
E-mail: certifiedadviser@redeye.se